Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|June 5, 2021
Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapyChisato Yokota, Naoki Kagawa, Koji Takano, et al.
Cancer Gene Therapy|January 8, 2021
Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer modelSeisuke Tanigawa, Mitsugu Fujita, Chiami Moyama, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2020
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptidesFumihiro Fujiki, Akihiro Tsuboi, Soyoko Morimoto, et al.
Journal of Neuro-Oncology|November 18, 2011
Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomographyHideyuki Arita, Manabu Kinoshita, Yoshiko Okita, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2018
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant gliomaAkihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, et al.
Journal of Neuro-Oncology|February 1, 2019
MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastomaJunichi Sakata, Takashi Sasayama, Kazuhiro Tanaka, et al.
Cancer Genetics|March 23, 2025
Immune prognostic model for glioblastoma based on the ssGSEA enrichment scoreTakanari Okamoto, Ryo Mizuta, Ayako Demachi-Okamura, et al.
The Oncologist|October 12, 2018
A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal CancerNaoya Hashimoto, Seiichiro Mitani, Hiroya Taniguchi, et al.
Journal of Neurosurgery|January 17, 2012
Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant gliomaYasuyoshi Chiba, Manabu Kinoshita, Yoshiko Okita, et al.
European Journal of Cancer (Oxford, England : 1990)|May 23, 2026
Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytomaYoshiko Hashii, Hiroyuki Fujisaki, Keita Terashima, et al.
Pageof 17